Brawley Otis W (CIK 0001213029)

Latest company ownership

Shares held
35,640
Last filed at
May 19, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2025Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 31, 2025 Apr 2, 2025 Lyell Immunopharma, Inc. Director Buy 91.3 +35,640 100.00% ✗ $20K